# Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy

> **NCT05140941** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Catherine Anne Chappell** · enrollment: 100 (estimated)

## Conditions studied

- Hepatitis C, Chronic
- Pregnancy; Infection

## Interventions

- **DRUG:** Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet

## Key facts

- **NCT ID:** NCT05140941
- **Lead sponsor:** Catherine Anne Chappell
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-04-04
- **Primary completion:** 2026-08
- **Final completion:** 2027-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05140941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05140941, "Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05140941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*